A 16-year-old mare was presented as an emergency to the Equine Hospital of the Veterinary School of Lyon, with a 1-month history of respiratory distress. On admission the mare was in poor body condition, with severe inspiratory and expiratory dyspnoea associated with severe hypoxaemia and marked tachycardia. Wheezes were auscultated. A pulmonary biopsy revealed fibrosis of about 40% of the parenchyma. Following an episode of atrial fibrillation, an echocardiogram was carried out which revealed signs of pulmonary hypertension, consistent with cor pulmonale. Despite the lack of aetiologic explanation for the primary pulmonary disease, the general condition of the mare improved with the administration of high-dosed corticoids and antimicrobial therapy.
Introduction
Cor pulmonale is cardiac remodelling, uncommonly observed in horses, secondary to pulmonary hypertension leading to dilatation and hypertrophy of the right cardiac chambers. A few cases of cor pulmonale secondary to severe and chronic pulmonary diseases such as equine asthma (Davis et al. 2002; Sage et al. 2006; Hanka et al. 2015) or granulomatous pneumonia (Schwarzwald et al. 2006) have previously been reported and these were often associated with a poor prognosis.
This report describes a case of cor pulmonale secondary to pulmonary fibrosis, associated with severe hypoxaemia and paroxysmal atrial fibrillation. Findings of the clinical examination, chest radiography, cardiac ultrasound and blood gas analyses are detailed.
Case history
A 16-year-old mare, weighing 364 kg, was presented as an emergency with a 1-month history of dyspnoea that was first associated with a purulent and haemorrhagic nasal discharge. Initial medical treatment with ceftiofur for 8 days improved the discharge but not the respiratory distress. A naso-pharyngeal swab revealed Streptococcus equi subs. zooepidemicus sensitive to all tested antimicrobials. One month later a second veterinarian prescribed 3 weeks of i.m. corticosteroid therapy and oral clenbuterol, twice a day. Since the clinical progression of the mare was not satisfactory, she was referred to the hospital after 2 days of medical treatment. The mare had a history of strangles 2 years previously. She had not been vaccinated against influenza for several years and the deworming programme was unknown. She usually lived in a stable at night and outside during the day with other horses that did not present any similar clinical signs.
Clinical findings and treatment
Upon arrival at the clinic the mare was calm and in poor body condition (body condition score 3/9). The clinical examination revealed tachycardia (100 beats/min), cyanotic mucous membranes, tachypnoea (36 breaths/min) associated with severe mixed dyspnoea and nasal flaring. Marked bilateral pulmonary wheezes were heard on thoracic auscultation. The heart rhythm was regular without any murmur.
A complete blood count (CBC) revealed marked haemoconcentration (RBC 12.07 9 10 12 /L, haematocrit 57.9% haemoglobin 20.1 g/dL) and marked neutrophilic leucocytosis (WBC 17.06 9 10 9 /L, neutrophils 13.5 9 10 9 /L). Serum
(49 g/L) and hyperlactataemia (3.49 mmol/L). An arterial blood sample confirmed the suspicion of severe hypoxaemia (PaO 2 42 mmHg, SO2 82%, PCO 2 50 mmHg). Finally, pulmonary ultrasonography was carried out. Unspecific multifocal B lines were observed throughout the lungs, especially on the right side.
The mare was hospitalised in the critical care unit and rapidly given intranasal oxygen (10 L/min). She was placed on balanced polyionic i.v. fluids 3 L/h (Ringer Lactate 1 ) that were decreased to 1.5 L/h 24 h later, trimethoprimsulfadoxine 15 mg/kg bwt i.v. q. 12 h (Borgal 2 ) and flunixin 1.1 mg/kg bwt i.v. q. 12 h (Meflosyl 3 ). Chest radiographs displayed a moderate and diffuse interstitial miliary lung pattern (Fig 1) . A cytologic analysis of a trans-tracheal wash (TTW) showed a mild suppurative inflammation without any evidence of microorganisms, based on a large amount of mucus containing Curshmann spirals and partly degenerated neutrophils (84%). Bacterial culture revealed Streptococcus equi zooepidemicus, sensitive to every tested antimicrobial agent, including the trimethoprim-sulfadoxine she was already given. According to a multi-PCR analysis, the nasopharyngeal swabs were negative for EHV (equine herpes virus) 1, 2, 4 and 5, EIV (equine influenza virus) and ERV (equine rhinitis virus) A and B. An ultrasound-guided transthoracic pulmonary biopsy revealed a severe multifocal interstitial pulmonary fibrosis involving about 40% of the pulmonary parenchyma, associated with mild hyperplasia of the bronchiolar epithelium and intraluminal mucus accumulation (Fig 2) . Finally, to rule out any general or neoplastic inflammatory process, abdominal paracentesis, transrectal palpation and abdominal ultrasonography were carried out, without any significant abnormalities found. In the 
Case progression and further examination
During her stay tachycardia, from 60 to 72 beats/min, a marked retrograde jugular pulse and tachypnoea from 32 to 40 breaths/min persisted. An intermittent, non-productive, cough developed after 4 days. Repeated CBC confirmed that the previous haemoconcentration was improved despite persistently high values (RBC 9.6 9 10 12 /L, haematocrit 43.6% haemoglobin 16.5 g/dL) while the white blood cell count decreased to within normal limits (WBC 8.5 9 10 9 /L, neutrophils 5.6 9 10 9 /L). Nine days after admission, the mare developed an irregularly irregular cardiac rhythm associated with severe tachycardia up to 90 beats/min. An electrocardiogram was consistent with atrial fibrillation (Fig 3) . An ionogram revealed mild hypokalaemia (2.3 mmol/L) and slight hypocalcaemia (1.25 mmol/L). The intravenous fluid bags was supplemented with potassium chloride and cardiac sonography was carried out. This examination revealed signs of pulmonary © 2018 EVJ Ltd e6 Cor pulmonale secondary to pulmonary fibrosis hypertension characterised by a dilatation and hypertrophy of the right cardiac chambers (maximal internal diameter of the right ventricle in diastole: 7 cm, maximal internal diameter of the right ventricle in systole: 5 cm, diameter of the right atrium: 6.5 cm) and a dilatation of the pulmonary trunk (6 cm; Figs 4 and 5). Minor pulmonary and tricuspid regurgitations without visible valvular changes were also observed and thought to be secondary to dilatation of the right side of the heart (Figs 6 and 7). No evidence of left sided cardiac disease was observed. The size of the left side of the heart was decreased due to hypovolaemia, and the cardiac contractility was irregular and constantly changing, which was consistent with modifications due to atrial fibrillation. A diagnosis of cor pulmonale was made based on the presence of signs of pulmonary hypertension without evidence of primary cardiac disease and considering the concomitance of the severely associated pulmonary disease.
The following day, the hypokalaemia and arrhythmia were resolved, despite a persistent tachycardia around 90 beats/ min. A new episode of atrial fibrillation appeared a few days later and resolved spontaneously within a few hours. Several new arterial blood samples taken following admission confirmed persistent hypoxaemia despite the treatments (Fig 8) .
Despite the poor prognosis of the wide pulmonary fibrosis associated with a cardiopathy, the owner decided to continue with the medical treatment. A new therapeutic plan was then established with oxytetracycline 10 mg/kg bwt i.v. q. 12 h.
During the rest of her stay at the hospital, the dyspnoea continued to improve until having a subnormal respiratory curve. After 12 days, adventitious lung sounds heard during thoracic auscultation were no longer noted. At this point oxygen therapy and fluid therapy were stopped and the mare was closely monitored but remained stable. The coughing previously heard was significantly diminished. New arterial blood samples were taken and showed a marked improvement of the previous hypoxia as the days passed (PaO 2 77 mmHg, SO2 95%, PCO 2 45 mmHg, then PaO 2 81 mmHg, SO2 97%, PCO 2 35 mmHg). After 11 days of corticoid therapy, the dosage was progressively decreased, and 5 days later a new arterial blood sample was within normal limits for the first time (PaO 2 91 mmHg, SO2 97%, PCO 2 37 mmHg; Fig 8) . Although a follow-up pulmonary ultrasound and chest x-rays showed no visible improvement, the cardiac ultrasound, however, revealed a slight improvement with resolution of the dilation of the right side of the heart (maximal internal diameter of the right ventricle in diastole: 3.4 cm, maximal internal diameter of the right ventricle in systole: 2.2 cm, diameter of the right atrium: 4 cm) despite the persistence of the dilatation of the pulmonary artery (maximal diameter of 6 cm). At this point, the antimicrobial therapy was stopped.
Outcome
The mare was discharged 3 weeks after admission, with ongoing treatment with dexamethasone 0.065 mg/kg bwt i.m q. 12 h (Dexadreson 4 ) at decreasing doses. She was accidently injured with other horses the day following her return and corticoids were prematurely stopped because of multiple deep wounds, before being reinstated when these had healed. The respiratory function declined during this period of time, before improving again. Five months later, the mare was no longer dyspnoeic and had gained weight.
Discussion

Clinical evolution
Upon admission, the severity of the respiratory insufficiency presented by the mare was unusual. Hypoxaemia is defined as an O 2 saturation below 95% and/or PaO 2 below 80 mmHg. This last parameter can decrease, during intense exercise, down to 72 mmHg. A few cases reported hypoxaemia from severe pulmonary diseases in horses as low as 79 mmHg (Sage et al. 2006) , 71.4 mmHg (Schwarzwald et al. 2006 ) and 61 mmHg (Hanka et al. 2015) . In this case, the first arterial sample revealed a PaO 2 of 42 mmHg, which is significantly lower than normal. Many systemic consequences, related to hypoxia, can appear at this stage. In people, blurred vision, weakness or dizziness (Auckburally and Nyman 2017) can be observed. Equine haemoglobin has a higher oxygen affinity and so horses are physiologically more adapted to accommodate a poor oxygenated environment, and in this case the persistent haemoconcentration despite fluid therapy might have been related to increased production of red blood cells promoted by erythropoietin in response to the chronic and significant hypoxaemia. However, severe hypoxaemia during general anaesthesias can lead to muscular, cardiac and even cerebral lesions despite selfregulation reported in horses for maintaining sufficient cerebral perfusion (Manohar and Goetz 1998) . These systemic problems can become problematic for the quality of recovery. Although hypoxaemia is commonly encountered and reported in horses undergoing general anaesthesias, to our knowledge, this is the first case highlighting such a severe hypoxaemia in a standing adult horse.
Another particular point is the development, during hospitalisation, of pulmonary hypertension without a primary Cor pulmonale secondary to pulmonary fibrosis cardiac disease, secondary to a severe pulmonary parenchymal disease, also known as 'cor pulmonale'. This pathological condition is a consequence of increased pulmonary resistance secondary to pulmonary vascular or parenchymal disease, and is associated with pulmonary arterial hypertension resulting in right ventricular hypertrophy and dilatation, and heart failure. This cardiac lesion is often seen in people, small animals and cattle after chronic obstructive pulmonary disease (COPD), severe pulmonary thrombo-embolism or living at a high-altitude (>2500 m) leading to hypoxia. In horses it is very rare to be confronted by such a complication with pulmonary pathology which explains why it is poorly documented. Indeed, their cardiovascular system is able to maintain a normal right cardiac function even in the case of chronic pulmonary diseases such as recurrent airway obstruction (RAO) (Slater 2006 ). However, rare cases of this cardiac remodelling in horses have been reported after severe RAO (Davis et al. 2002; Sage et al. 2006; Hanka et al. 2015) or granulomatous pneumonia (Schwarzwald et al. 2006) but to the best of the authors' knowledge this is the first reported case of cor pulmonale secondary to pulmonary fibrosis in a horse. It should also be noted that, besides the right ventricle hypertrophy and dilatation, the cardiac adjustment was so advanced that the mare presented with episodes of atrial fibrillation, possibly subsequent to right atrial dilatation.
The clinical improvement, despite the severity and irreversibility of the lesions, should also be highlighted. Added to the cardiac remodelling, histologic analysis of the pulmonary biopsy revealed that there was fibrosis of about 40% of the parenchyma, meaning definitive loss of function. Pulmonary fibrosis was reported in several cases of equine multinodular pulmonary fibrosis possibly related to EHV-5 (Williams et al. 2007 (Williams et al. , 2013 Back et al. 2012; Panziera et al. 2014; Estima-Silva et al. 2017) . In this case, the absence of observed or reported fever and nodular appearance of the pulmonary parenchyma, in addition to the negative PCR analysis for EHV-5, was not consistent with this viral cause. Despite the severe lesions of two main systems of the organism, the general condition and comfort of the mare significantly improved during hospitalisation. Therefore, ongoing inflammation of the pulmonary parenchyma persisted and directly affected the presenting signs. She was discharged with a respiratory frequency and respiration curve within normal limits and arterial blood gas similar to those of a healthy horse.
Complementary examinations
Echocardiography enabled diagnosis of cor pulmonale, which can only be done once primary cardiac diseases and pulmonary hypertension secondary to left heart failure are ruled out.
Right heart catheterisation is the gold standard to confirm pulmonary hypertension and assess its severity. In a study that measured pulmonary artery pressures in 20 healthy horses, a mean of 17.5 mmHg was recorded (minimum 15.4 mmHg, maximum 19.6 mmHg), which is consistent with previous results (Wilsterman et al. 2009 ). In comparison, pulmonary artery pressures measured in 10 horses affected with chronic obstructive pulmonary disease was more than twice the pressure of healthy ones (mean 44.56 mmHg, minimum 31.01 mmHg, maximum 65.45 mmHg) (Dixon 1978) . In the present case, and for technical reasons, this procedure was not performed.
Concerning the primary respiratory disease, chest radiographs revealed a moderate and diffuse interstitial miliary lung pattern primarily consistent with an infectious, allergic or toxic interstitial pneumonia. Pulmonary biopsy, naso-pharyngeal swab and transtracheal wash cytology and bacteriology could not establish the aetiology of the respiratory distress and the pulmonary fibrosis. However, some agents such has EHV5 or intracellular bacteria are not always easily isolated (Allam and Lemcke 1975; Pusterla et al. 2015) . The mare also had a history of strangles and was not adequately vaccinated. The fibrosis could therefore also be a residual lesion from previous pulmonary viral or bacterial infections, exposition to toxic agents or immune-mediated process. A bronchoalveolar lavage could have been performed to assess the active inflammation of the lungs. In this case, in view of the severe respiratory dyspnoea of the mare, it was decided not to carry out this procedure.
Therapeutic choices
The choice and the relevance of the different therapeutic plans established seem to have played a major role in the favourable outcome of the mare. Before being presented, she had been treated with ceftiofur for 8 days, then clenbuterol and corticosteroids at normal doses for 2 days. Despite the difficulty in assessing this last treatment because of the short duration, none of these treatments seem to have significantly improved the respiratory function. The first therapeutic plan decided during hospitalisation, based on trimethoprim-sulfadoxine (Borgal 2 ) and flunixin (Meflosyl 3 ), does not seem to have been effective in treating the underlying cause either. When we received the results of the TTW bacteriology, the multi-sensitivity of the only bacteria cultured confirmed that it was not the primary aetiologic agent. The anti-inflammatory medication was then changed and corticoids were re-established at the initial dose of 0.1 mg/kg bwt i.v. q. 24 h of dexamethasone (Dexadreson   3   ) . Antimicrobial agents were kept to prevent any secondary infection. After 24 h of corticoid therapy, the first results were seen. An improvement of the respiratory comfort was observed a few hours after the first injection in the morning, but it declined again at the end of the day. A new protocol of half-dose injections (0.05 mg/kg bwt q. 12 h) twice a day was then initiated but did not seem to be effective. Corticoids were finally given at a full dose twice a day (0.1 mg/kg bwt q. 12 h). This high dosage led to a significant improvement of the respiratory function of the mare. As laminitis can be a major complication after administration of high doses of corticoids over a long period, she was watched closely for any warning signs, that never appeared. However, polydipsia was noted as the mare drank from 50 to 70 L of water a day. A few days before the discharge, the corticoid dosage was progressively decreased until reaching a minimal efficient dose of 0.065 mg/kg bwt i.m. q. 12 h. This response to high doses of corticoids could also be consistent with a chronic obstructive pneumopathy.
Facing the lack of clinical improvement, oxytetracycline at 10 mg/kg bwt i.v. q. 12 h was used as an alternative antimicrobial therapy with action against potential intracellular organisms. However, none of the laboratory evaluations revealed the presence of such aetiologic agents. Even if mycoplasmas were not directly detected, this aetiologic hypothesis could not be ruled out as cases of pulmonary fibrosis due to mycoplasma pneumonia have been reported in the literature in other species, and as the presence of this bacteria is probably under-estimated (Allam and Lemcke 1975; Kaufman et al. 1980; Tablan and Reyes 1985; Hardy et al. 2002) .
Treatment of cor pulmonale usually includes supplemental oxygen, as well as diuretics to control the pulmonary hypertension and the oedema consecutive to right heart dysfunction. However, diuretics should be used with caution in hypoxaemic patients, as they reduce cardiac preload to both ventricles, blood volume and can cause metabolic alkalosis which can result in respiratory compensation with an increase in CO2. Since the mare did not present signs of right heart failure, diuretics were not used in this case. Use of digoxin as a treatment for cor pulmonale is controversial. Digoxin therapy helps to improve ventricular ejection fraction and to slow down the ventricular rate which can be particularly helpful in patients with atrial fibrillation. However, its use is only recommended in cases of left heart failure, since it does not significantly improve right ventricular ejection fraction (Alajaji et al. 2016) . Finally, ACE-inhibitors were not used in this case. Despite a recent study that showed no significant improvement acutely, these drugs are reported to help reduce pulmonary hypertension and decrease right ventricular hypertrophy (Romano and Peterson 2000) .
Conclusion
This report describes a case of cor pulmonale secondary to pulmonary fibrosis, associated with severe hypoxaemia. Cor pulmonale is rarely observed in horses, and there is very little published information about prognosis and outcome of this cardiac remodelling over the long term.
The treatment of the underlying cause is essential to prevent any worsening of the lesions that could lead to a global cardiac insufficiency.
